NEXGEL, Inc. (NXGL) vs Profusa, Inc. Common Stock (PFSA)

A side-by-side comparison of NEXGEL, Inc. and Profusa, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
NEXGEL, Inc. logo
NXGL
NEXGEL, Inc.
$1M
$0.17HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT
Profusa, Inc. Common Stock logo
PFSA
Profusa, Inc. Common Stock
$2M
$1.70HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT

Total return — NXGL vs PFSA

growth of $100 · dividends reinvested · last 1y
NXGL -93.8% (-93.8%/yr)PFSA -100.0% (-100.0%/yr)NXGL compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $1002026$6$0
NXGL PFSA

NXGL vs PFSA: by the numbers

  • •PFSA is the larger company ($2M vs $1M market cap).
  • •Both run net losses; PFSA's is the smaller (0.00% vs -51.26% net margin).

Metrics side by side

Valuation

MetricNXGLPFSA
P/S ratio0.12N/A
P/B ratio0.29N/A

Profitability

MetricNXGLPFSA
Gross margin35.07%0.00%
Operating margin-29.35%0.00%
Net margin-51.26%0.00%
ROE-124.97%N/A
ROIC-41.80%N/A

Growth (annualized)

MetricNXGLPFSA
Revenue CAGR (5Y)63.69%N/A

Go deeper

Full NXGL analysisFull PFSA analysisInteractive comparison tool

Dig into the metrics

NEXGEL ROEProfusa, Inc. Common Stock ROENEXGEL operating marginProfusa, Inc. Common Stock operating marginNEXGEL revenue growthProfusa, Inc. Common Stock revenue growthNEXGEL free cash flowProfusa, Inc. Common Stock free cash flow

NEXGEL & Profusa, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.